Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database

被引：10
|
作者：
Carnovale, Carla [1 ]
Gentili, Marta [1 ]
Antoniazzi, Stefania [2 ]
Clementi, Emilio [3 ,4 ]
Radice, Sonia [1 ]
机构：
[1] Univ Milan, ASST Fatebenefratelli Sacco Univ Hosp, Clin Pharmacol Unit, Dept Biomed & Clin Sci, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[3] Univ Milan, Sacco Univ Hosp, CNR, Dept Biomed & Clin Sci,Clin Pharmacol Unit,Inst N, Milan, Italy
[4] IRCCS E Medea Bosisio Parini LC, La Nostra Famiglia, Italy
来源：
MUSCLE & NERVE | 2017年 / 56卷 / 06期
关键词：
D O I：
10.1002/mus.25972
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E176 / E178
页数：3
相关论文
共 50 条
  • [1] LEVETIRACETAM-INDUCED RHABDOMYOLYSIS: ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE EVENT REPORTING SYSTEM DATABASE Reply
    Casanova-Molla, J.
    Valls-Sole, J.
    MUSCLE & NERVE, 2017, 56 (06) : E178 - E178
  • [2] An assessment of drug-induced rhabdomyolysis cases within the US Food and Drug Administration Adverse Event Reporting System
    Bin Dayel, Faten
    Alfirevic, Ana
    Turner, Richard
    Chadwick, Amy
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1617 - 1618
  • [3] Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
    Toki T.
    Ono S.
    Drugs - Real World Outcomes, 2018, 5 (2) : 117 - 128
  • [4] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Wei, Lianhui
    Tian, Ye
    Chen, Xiao
    Guo, Xiaojing
    Chen, Chenxin
    Zheng, Yi
    Xu, Jinfang
    Ye, Xiaofei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 622 - 629
  • [5] Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Ahmed, Abdul Mannan Faruk
    Maheswari, Eswaran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 306 - 306
  • [6] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [7] Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
    Fang, Runan
    Zhou, Yang
    Han, Lu
    Chen, Wenjing
    Guan, Ning
    Li, Jianhong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Drug-Induced Hair Loss: Analysis of the Food and Drug Administration's Adverse Events Reporting System Database
    Hill, Rachel C.
    Zeldin, Steven D.
    Lipner, Shari R.
    SKIN APPENDAGE DISORDERS, 2025, 11 (01) : 63 - 69
  • [9] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [10] Drug-Induced Rhabdomyolysis: Reports from the Italian Database of Spontaneous Reporting of Adverse Drug Reactions
    Donati, M.
    Cuconato, V.
    Di Girolamo, M.
    Cocci, A.
    Conti, V.
    Moretti, U.
    DRUG SAFETY, 2010, 33 (10) : 930 - 930
12345